What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
Corporation (NYSE:HAE) , according to a February 17, 2026, SEC filing, selling 498,317 shares previously worth $24.29 million. What happened According to a February 17, 2026, SEC filing , Invenomic Capital Management sold its entire stake of 498,317 shares in Haemonetics Corporation. The net position change for the quarter was $24.29 million. What else to know The fund's exit from Haemonetics Corporation reduced the position from 1.2% of 13F AUM in the prior quarter to zero post-filing. Top holdings after the filing: NASDAQ: VTRS: $69.64 million (3.4% of AUM) NYSE: GPN: $61.73 million (3.0% of AUM) NASDAQ: XRAY: $58.66 million (2.8% of AUM) NASDAQ: AKAM: $58.59 million (2.8% of AUM) NYSE: EGO: $53.75 million (2.6% of AUM) As of Friday, shares of Haemonetics Corporation were priced at $58.58, down 9% over the past year and well underperforming the S&P 500's roughly 16% gain in the same period. Company overview Metric Value Revenue (TTM) $1.32 billion N
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (HAE) had its price target lowered by Citigroup Inc. from $75.00 to $70.00. They now have a "neutral" rating on the stock.MarketBeat
- Here's Why Haemonetics (HAE) is a Strong Value Stock [Yahoo! Finance]Yahoo! Finance
- Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS TechnologyPR Newswire
- Haemonetics to Present at Raymond James 47th Annual Institutional Investors ConferencePR Newswire
- Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 [Yahoo! Finance]Yahoo! Finance
HAE
Earnings
- 2/6/26 - Beat
HAE
Sec Filings
- 3/3/26 - Form SCHEDULE
- 3/3/26 - Form 8-K
- 2/13/26 - Form SCHEDULE
- HAE's page on the SEC website